Findings reveal sex differences in coronary artery disease outcomes, suggesting risk stratification may underestimate adverse events in women.
This study demonstrates important sex-based differences in CAD phenotype and prognosis. Women had lower plaque burden, yet experienced adverse events with lower CAD-RADS, suggesting that current risk stratification may underestimate their risk. AI-QCT provides enhanced plaque characterization, which may in the future improve individualized assessment, especially in women.
No takes yet. Share an insight, caveat, or question.
Molnár et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: